Results 101 to 110 of about 10,764 (219)

Pseudomonas aeruginosa PAO1 outer membrane vesicles-diphtheria toxoid conjugate as a vaccine candidate in a murine burn model. [PDF]

Sci Rep, 2022
Zare Banadkoki E, Rasooli I, Ghazanfari T, Siadat SD, Shafiee Ardestani M, Owlia P.   +5 more
europepmc   +1 more source

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal. [PDF]

Hum Vaccin Immunother, 2023
Chaudhary S, Shah GS, Bhatta NK, Poudel P, Rai B, Uranw S, Tripathi PM, Khanal B, Ghimire A, Rai N, Gupta BP, Vemula S, Wartel TA, Sahastrabuddhe S, Saluja T.   +14 more
europepmc   +1 more source

Poster Session 1

Pregnancy, Volume 2, Issue S1, January 2026.
wiley   +1 more source

Seroprevalence of Diphtheria and Tetanus Immunoglobulin G among the General Health Population in Guangzhou, China

Vaccines
A seroepidemiological study was conducted in 2018 to assess diphtheria and tetanus antibodies in Guangzhou, China. Diphtheria and tetanus antibody concentrations were measured with an enzyme-linked immunosorbent assay.
Qing He, Yejian Wu, Shuiping Hou, Lei Luo, Zhoubin Zhang   +4 more
doaj   +1 more source

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults

Human Vaccines & Immunotherapeutics, 2017
Background: An acellular Pertussis (aP) vaccine containing recombinant genetically detoxified Pertussis Toxin (PTgen), Filamentous Hemagglutinin (FHA) and Pertactin (PRN) has been developed by BioNet-Asia (BioNet).
Chukiat Sirivichayakul, Pornthep Chanthavanich, Kriengsak Limkittikul, Claire-Anne Siegrist, Wassana Wijagkanalan, Pailinrut Chinwangso, Jean Petre, Pham Hong Thai, Mukesh Chauhan, Simonetta Viviani   +9 more
doaj   +1 more source

Validation of a diphtheria toxoid multiplex bead assay for serosurveys. [PDF]

Diagn Microbiol Infect Dis, 2021
Scobie HM, Khetsuriani N, Efstratiou A, Priest JW.   +3 more
europepmc   +1 more source

Epitope Profiling of Diphtheria Toxoid Provides Enhanced Monitoring for Consistency Testing during Manufacturing Process Changes. [PDF]

Vaccines (Basel), 2022
Houy C, Ming M, Ettorre L, Jin R, Thangavadivel N, Chen T, Su J, Gajewska B.   +7 more
europepmc   +1 more source

The geometry of diphtheria toxoid CRM197 channel assessed by thiazolium salts and nonelectrolytes. [PDF]

Biophys J, 2021
Shatursky OY, Manoilov KY, Gorbatiuk OB, Usenko MO, Zhukova DA, Vovk AI, Kobzar OL, Trikash IO, Borisova TA, Kolibo DV, Komisarenko SV.   +10 more
europepmc   +1 more source

Waning rate of immunity and duration of protective immunity against diphtheria toxoid as a function of age and number of doses: Systematic review and quantitative data analysis. [PDF]

Hum Vaccin Immunother, 2022
Kitamura N, Bahkali K, Chem ED, Quilty BJ, Edwards T, Toizumi M, Yoshida LM.   +6 more
europepmc   +1 more source

Evaluation of Immunogenicity of Yersinia enterocolitica O:8 Oligopolysaccaride-DiphtheriaeToxoide Conjugate in Mice

Journal of Ardabil University of Medical Sciences, 2015
Background & objectives: Yersiniosis is created by Yersinia enterocolitica O:8 and causes problems in the world especialy in cold and mild countries.
SM Rezavian, R Shapouri
doaj